NIH-funded research R01 grant

Advancing AI Fairness for Trustworthy Liver Organ Allocation

Official title: SCH: Advancing AI Fairness for Trustworthy Liver Organ Allocation

Funded at Florida International University · NIH-11579061 · Data updated 2026-11-12

A funded NIH project will use AI to help fairly allocate donated livers to patients with liver disease, aiming to reduce bias and improve access for those in need.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida International University
NIH-funded
Lab location1 site (Miami, United States)
Project startSeptember 1, 2026
Project endJune 30, 2030
Funding year2026
Award (this year)$300,000
NIH project number1R01EB041351-01
Project IDNIH-11579061 on NIH RePORTER

Who could benefit from this research

Could help

People with end-stage liver disease, including cirrhosis and liver cancer, who are potential transplant candidates.

Less likely to help

Patients not on the transplant waiting list or those unlikely to be organ recipients under the current system may not see direct benefits.

What this research studies

This project focuses on improving how AI helps decide who gets a liver transplant, considering not only medical urgency but also fairness and real-world data limitations. It tackles the challenge of censored information since many transplant outcomes are not fully observed yet. The team will develop AI fairness methods that balance equal treatment with practical usefulness for clinicians. The work is designed to be understandable to clinicians and patients, so decisions can be explained and trusted. The effort is anchored at Florida International University in Miami, led by Wenbin Zhang and colleagues, with a focus on liver disease patients including cirrhosis and liver cancer.

Why it matters

Potential benefit: If successful, patients with liver disease could experience more equitable access to transplant organs and clearer, more trustworthy allocation decisions.

How similar studies have gone: Prior AI fairness work has shown promise in improving equity, but this project addresses unique censoring and interaction challenges specific to liver allocation.

Where this research is happening

  • Florida International University
    Miami, United States
    Active

Researchers

  • Principal investigator: Zhang, Wenbin — Florida International University
  • Study coordinator: Zhang, Wenbin

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.